Providers and payers certainly face some formidable challenges when it comes to gene therapy, but it pales in comparison to ...

A new study has brought scientists one step further in the direction of developing a cure for a brutal group of rare brain disorders known as SYNGAP1-related disorders, or SRDs. Researchers were able ...

Russian scientists are reportedly developing a world-first gene therapy targeting the RAGE receptor to halt cellular aging.

Not intended for UK Media Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency ...